Abbott Laboratories - ABT Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $125.63
Forecasted Upside: 12.82%
Number of Analysts: 15
Breakdown:
1 Sell Ratings
3 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$111.35 As of 02/7/2023 12:58 PM ET

▲ +0.6 (0.54%)

1 month | 3 months | 12 months

Get New Abbott Laboratories Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ABT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABT

^$125.63

▲ +12.82% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for Abbott Laboratories in the last 3 months. The average price target is $125.63, with a high forecast of $140.00 and a low forecast of $110.00. The average price target represents a 12.82% upside from the last price of $111.35.

Current Consensus is Buy

The current consensus among 15 polled investment analysts is to buy stock in Abbott Laboratories. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
12 buy ratings
2 hold ratings
2 sell ratings

Ratings as of

8/16/2021

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

11/14/2021

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/12/2022

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/13/2022

0 strong buy ratings
11 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

8/11/2022

0 strong buy ratings
10 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

11/9/2022

0 strong buy ratings
10 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

1/8/2023

0 strong buy ratings
11 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

2/7/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
1/27/2023	Barclays	Boost Target	Overweight	$122.00 ➝ $125.00	Low
1/26/2023	Stifel Nicolaus	Boost Target	Buy	$110.00 ➝ $125.00	Low
1/26/2023	Raymond James	Boost Target	Outperform	$109.00 ➝ $123.00	Low
1/26/2023	Sanford C. Bernstein	Boost Target	Outperform	$125.00 ➝ $132.00	Low
1/24/2023	Mizuho	Boost Target	Neutral	$105.00 ➝ $110.00	Low
1/6/2023	Morgan Stanley	Boost Target	Overweight	$117.00 ➝ $133.00	Low
1/4/2023	Barclays	Boost Target		$114.00 ➝ $122.00	Low
12/12/2022	Citigroup	Boost Target	Buy	$114.00 ➝ $125.00	Low
10/26/2022	Mizuho	Initiated Coverage	Neutral	$105.00	Low
10/21/2022	Raymond James	Lower Target	Outperform	$117.00 ➝ $109.00	Low
10/20/2022	Evercore ISI	Lower Target		$110.00	Low
10/20/2022	Morgan Stanley	Lower Target	Overweight	$126.00 ➝ $117.00	Low
10/20/2022	Royal Bank of Canada	Lower Target	Outperform	$132.00 ➝ $126.00	Low
10/17/2022	Barclays	Initiated Coverage	Overweight	$118.00	Low
10/17/2022	BTIG Research	Lower Target	Buy	$126.00 ➝ $123.00	Low
10/12/2022	Jefferies Financial Group	Initiated Coverage	Hold	$110.00	Low
10/11/2022	Morgan Stanley	Lower Target	Overweight	$132.00 ➝ $126.00	Low
10/10/2022	Wells Fargo & Company	Lower Target	Overweight	$150.00 ➝ $140.00	Low
10/5/2022	Citigroup	Lower Target		$123.00 ➝ $117.00	Low
8/25/2022	Erste Group Bank	Downgrade	Buy ➝ Hold		Low
7/27/2022	UBS Group	Lower Target	Buy	$142.00 ➝ $128.00	Low
7/22/2022	Evercore ISI	Lower Target		$112.00	Low
7/21/2022	Morgan Stanley	Lower Target	Overweight	$134.00 ➝ $132.00	Low
7/21/2022	Royal Bank of Canada	Lower Target		$143.00 ➝ $132.00	Low
7/21/2022	Citigroup	Lower Target	Buy	$125.00 ➝ $123.00	Low
7/18/2022	BTIG Research	Lower Target	Buy	$130.00 ➝ $126.00	Low
7/18/2022	Stifel Nicolaus	Lower Target		$136.00 ➝ $126.00	Low
7/15/2022	Morgan Stanley	Lower Target	Overweight	$145.00 ➝ $134.00	Low
7/13/2022	Cowen	Lower Target		$150.00 ➝ $130.00	Low
7/13/2022	Cowen	Lower Target		$150.00 ➝ $130.00	Low
7/5/2022	Wolfe Research	Initiated Coverage	Underperform		N/A
6/24/2022	BTIG Research	Lower Target	Buy	$140.00 ➝ $130.00	Low
6/7/2022	Morgan Stanley	Lower Target	Overweight	$151.00 ➝ $145.00	Medium
5/17/2022	Citigroup	Lower Target	NA	$154.00 ➝ $125.00	N/A
4/21/2022	Royal Bank of Canada	Lower Target	Outperform	$146.00 ➝ $143.00	Low
4/21/2022	Raymond James	Lower Target	Outperform	$143.00 ➝ $135.00	Low
4/8/2022	Wells Fargo & Company	Lower Target	Overweight	$155.00 ➝ $150.00	Medium
3/1/2022	Bank of America	Initiated Coverage	Buy ➝ Buy	$140.00	Medium
1/27/2022	Credit Suisse Group	Boost Target	Outperform	$138.00 ➝ $139.00	Low
1/27/2022	UBS Group	Boost Target	Buy ➝ Buy	$138.00 ➝ $142.00	Low
1/27/2022	Morgan Stanley	Lower Target	Overweight	$157.00 ➝ $151.00	Low
1/27/2022	Raymond James	Lower Target	Outperform	$150.00 ➝ $143.00	Low
1/26/2022	BTIG Research	Lower Target		$143.00 ➝ $138.00	Low
1/10/2022	Cowen	Boost Target		$140.00 ➝ $150.00	Medium
1/7/2022	Morgan Stanley	Boost Target	Overweight	$146.00 ➝ $157.00	Low
12/23/2021	Raymond James	Lower Target		$150.00 ➝ $134.00	Low
12/22/2021	Raymond James	Boost Target	Outperform	$134.00 ➝ $150.00	High
12/9/2021	Royal Bank of Canada	Initiated Coverage	Outperform	$146.00	Low
10/27/2021	Atlantic Securities	Upgrade	Neutral ➝ Overweight	$144.00	High
10/21/2021	Morgan Stanley	Boost Target	Overweight	$136.00 ➝ $146.00	High
10/21/2021	SVB Leerink	Reiterated Rating	Market Perform	$128.00 ➝ $140.00	High
10/21/2021	Raymond James	Boost Target	Positive ➝ Outperform	$128.00 ➝ $134.00	Medium
10/14/2021	Redburn Partners	Initiated Coverage	Neutral	$103.13 ➝ $132.28	Low
10/8/2021	Cowen	Reiterated Rating	Buy	$140.00	Medium
10/1/2021	Citigroup	Boost Target	Buy	$135.00 ➝ $140.00	Medium
8/31/2021	BTIG Research	Boost Target	Buy	$126.00 ➝ $136.00	Low
8/23/2021	Cowen	Boost Target	Positive ➝ Outperform	$125.00 ➝ $140.00	Medium
7/23/2021	Morgan Stanley	Boost Target	Overweight	$126.00 ➝ $136.00	Low
7/23/2021	Credit Suisse Group	Boost Target	Outperform	$120.00 ➝ $130.00	Medium
7/23/2021	Raymond James	Boost Target	Outperform	$116.00 ➝ $128.00	Medium
7/20/2021	SVB Leerink	Boost Target	Market Perform	$115.00 ➝ $128.00	Low
7/12/2021	Wells Fargo & Company	Boost Target	Market Perform ➝ Overweight	$125.00 ➝ $135.00	Low
6/2/2021	BTIG Research	Lower Target	Buy	$140.00 ➝ $120.00	Medium
6/2/2021	Credit Suisse Group	Lower Target	Outperform	$133.00 ➝ $120.00	Medium
6/2/2021	Barclays	Lower Target	Overweight	$150.00 ➝ $125.00	Medium
6/2/2021	Wells Fargo & Company	Lower Target	Overweight	$137.00 ➝ $125.00	Medium
6/2/2021	Raymond James	Lower Target	Outperform	$130.00 ➝ $116.00	Medium
6/2/2021	Morgan Stanley	Lower Target	Overweight	$140.00 ➝ $126.00	Medium
6/2/2021	Citigroup	Reiterated Rating	Buy	$138.00 ➝ $125.00	Medium
5/24/2021	Barclays	Initiated Coverage	Overweight	$150.00	Medium
4/21/2021	Morgan Stanley	Boost Target	Overweight	$136.00 ➝ $140.00	Medium
4/20/2021	William Blair	Reiterated Rating	Outperform		Low
4/15/2021	Atlantic Securities	Initiated Coverage	Neutral	$122.00	High
3/11/2021	Raymond James	Boost Target	Outperform	$126.00 ➝ $130.00	Low
1/28/2021	Wells Fargo & Company	Boost Target		$128.00 ➝ $137.00	Medium
1/28/2021	Cowen	Boost Target	Outperform	$113.00 ➝ $140.00	Medium
1/28/2021	Credit Suisse Group	Boost Target	Outperform	$118.00 ➝ $130.00	High
1/28/2021	Morgan Stanley	Boost Target	Overweight	$126.00 ➝ $136.00	High
1/28/2021	SVB Leerink	Boost Target	Market Perform	$115.00 ➝ $128.00	High
1/28/2021	Raymond James	Boost Target	Outperform	$114.00 ➝ $126.00	High
1/28/2021	BTIG Research	Upgrade	Neutral ➝ Buy	$140.00	High
12/15/2020	Morgan Stanley	Boost Target	Overweight	$121.00 ➝ $126.00	Low
11/19/2020	Morgan Stanley	Boost Target	Overweight	$117.00 ➝ $121.00	Low
10/22/2020	Jefferies Financial Group	Boost Target	Buy	$113.00 ➝ $123.00	High
10/22/2020	Credit Suisse Group	Lower Target	Outperform	$136.00 ➝ $118.00	High
10/22/2020	Raymond James	Boost Target	Market Perform ➝ Outperform	$102.00 ➝ $114.00	High
10/22/2020	Morgan Stanley	Boost Target	Overweight	$112.00 ➝ $117.00	High
10/22/2020	SVB Leerink	Boost Target	Positive ➝ Market Perform	$110.00 ➝ $115.00	High
10/9/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$110.00 ➝ $125.00	Low
10/7/2020	Wells Fargo & Company	Boost Target	Overweight	$120.00 ➝ $122.00	Low
9/11/2020	Wolfe Research	Initiated Coverage	Outperform	$124.00	Low
9/2/2020	The Goldman Sachs Group	Set Target	Sell	$94.00	Low
8/31/2020	Credit Suisse Group	Boost Target	Outperform	$109.00 ➝ $136.00	Low
8/28/2020	Citigroup	Boost Target	Buy	$110.00 ➝ $130.00	High
8/27/2020	BTIG Research	Reiterated Rating	Hold		High
8/27/2020	The Goldman Sachs Group	Set Target	Sell	$94.00	Medium
8/27/2020	Wells Fargo & Company	Boost Target		$107.00 ➝ $115.00	Medium
8/27/2020	Stifel Nicolaus	Boost Target	Buy	$108.00 ➝ $115.00	Low
8/27/2020	Morgan Stanley	Boost Target	Overweight	$106.00 ➝ $112.00	Medium
7/23/2020	Argus	Boost Target		$110.00 ➝ $125.00	Low
7/20/2020	Bank of America	Boost Target	Buy	$95.00 ➝ $110.00	Medium
7/17/2020	SVB Leerink	Boost Target	Market Perform	$97.00 ➝ $110.00	High
7/17/2020	Morgan Stanley	Boost Target	Overweight	$100.00 ➝ $106.00	High
7/17/2020	Credit Suisse Group	Boost Target	Outperform	$106.00 ➝ $109.00	High
7/17/2020	Citigroup	Boost Target	Buy	$109.00 ➝ $110.00	Medium
7/9/2020	Wells Fargo & Company	Reiterated Rating	Buy	$107.00	Low
6/25/2020	Morgan Stanley	Lower Target	Overweight	$108.00 ➝ $100.00	High
5/31/2020	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$84.00	Medium
5/22/2020	Credit Suisse Group	Reiterated Rating	Buy	$106.00	Low
4/20/2020	Barclays	Boost Target	Overweight	$92.00 ➝ $100.00	Medium
4/17/2020	UBS Group	Boost Target	Buy	$105.00 ➝ $109.00	Low
4/17/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$88.00 ➝ $98.00	Low
4/17/2020	Stifel Nicolaus	Boost Target		$85.00 ➝ $108.00	Low
4/17/2020	Credit Suisse Group	Boost Target	Outperform	$95.00 ➝ $106.00	Medium
4/17/2020	Raymond James	Boost Target	Overweight ➝ Outperform	$92.00 ➝ $102.00	Low
4/17/2020	Citigroup	Boost Target	Buy	$87.00 ➝ $109.00	Medium
4/17/2020	Wells Fargo & Company	Boost Target	Overweight	$95.00 ➝ $107.00	Medium
4/16/2020	BTIG Research	Reiterated Rating	Hold		Low
4/16/2020	Cfra	Boost Target	Buy	$99.00 ➝ $101.00	Low
4/9/2020	Wells Fargo & Company	Boost Target	Overweight	$92.00 ➝ $95.00	Medium
4/9/2020	Raymond James	Lower Target	Outperform	$99.00 ➝ $92.00	Medium
4/8/2020	Wells Fargo & Company	Reiterated Rating	Buy		Medium
4/8/2020	SVB Leerink	Lower Target	Market Perform	$102.00 ➝ $93.00	High
4/3/2020	JPMorgan Chase & Co.	Lower Target	Overweight	$101.00 ➝ $88.00	Low
3/30/2020	Wells Fargo & Company	Reiterated Rating	Buy		Medium
3/27/2020	Citigroup	Lower Target	Buy	$96.00 ➝ $87.00	Medium
3/27/2020	Morgan Stanley	Lower Target	Overweight	$101.00 ➝ $96.00	Medium
3/6/2020	Credit Suisse Group	Lower Target	Outperform	$104.00 ➝ $94.00	High
3/4/2020	Citigroup	Initiated Coverage	Buy	$96.00	Medium
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$96.00	Low
2/6/2020	BTIG Research	Reiterated Rating	Hold		Low
1/23/2020	JPMorgan Chase & Co.	Lower Target		$96.00 ➝ $101.00	Low
1/23/2020	UBS Group	Boost Target	Buy	$99.00 ➝ $105.00	Low
1/23/2020	Wells Fargo & Company	Boost Target	Overweight	$97.00 ➝ $103.00	Medium
1/23/2020	Raymond James	Boost Target	Outperform	$90.00 ➝ $99.00	Medium
1/23/2020	Stifel Nicolaus	Boost Target	Buy	$95.00 ➝ $104.00	Medium
1/2/2020	Citigroup	Downgrade	Neutral ➝ Sell		High
1/2/2020	Evercore ISI	Downgrade	Outperform ➝ In-Line		High
1/2/2020	Guggenheim	Downgrade	Buy ➝ Neutral		Medium
12/17/2019	Morgan Stanley	Boost Target	Overweight	$93.00 ➝ $101.00	Medium
10/17/2019	William Blair	Reiterated Rating	Underperform		Low
10/17/2019	Credit Suisse Group	Boost Target	Outperform	$95.00 ➝ $98.00	Low
10/14/2019	Raymond James	Lower Target	Outperform	$93.00 ➝ $90.00	Low
7/18/2019	Jefferies Financial Group	Boost Target	Buy	$80.00 ➝ $98.00	Medium
7/18/2019	Cowen	Boost Target	Outperform	$86.00 ➝ $95.00	High
7/18/2019	Raymond James	Boost Target	Outperform	$87.00 ➝ $93.00	Medium
7/18/2019	BMO Capital Markets	Boost Target	Outperform	$87.00 ➝ $94.00	Medium
7/16/2019	Morgan Stanley	Boost Target	Overweight	$85.00 ➝ $93.00	Low
6/13/2019	Bank of America	Reiterated Rating	Buy	$81.00	Low
6/13/2019	Wells Fargo & Company	Boost Target	Outperform	$89.00 ➝ $91.00	Low
4/18/2019	William Blair	Reiterated Rating	Outperform		N/A
4/15/2019	Royal Bank of Canada	Boost Target	Buy	$82.00	Low
3/14/2019	Wells Fargo & Company	Reiterated Rating	Buy		High
3/8/2019	Barclays	Set Target	Buy	$84.00	Low
2/7/2019	Bank of America	Reiterated Rating	Buy ➝ Buy	$73.00 ➝ $81.00	Low
1/25/2019	Argus	Boost Target	Buy ➝ In-Line	$90.00	Low
1/24/2019	BTIG Research	Reiterated Rating	Hold		Medium
1/2/2019	Gabelli	Reiterated Rating	Buy		Low
1/2/2019	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$82.00 ➝ $85.00	Low
1/2/2019	Citigroup	Downgrade	Neutral ➝ Sell	$72.00 ➝ $68.00	High
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$82.00	Low
12/9/2018	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$74.10	Low
12/4/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$80.00 ➝ $82.00	High
11/30/2018	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$78.00 ➝ $81.00	Low
11/27/2018	UBS Group	Initiated Coverage	Buy	$83.00	High
10/18/2018	Jefferies Financial Group	Reiterated Rating	In-Line ➝ Buy	$80.00	High
10/18/2018	Raymond James	Boost Target	Outperform ➝ Outperform	$77.00 ➝ $79.00	High
10/18/2018	BTIG Research	Reiterated Rating	Hold		High
10/15/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$80.00	High
10/11/2018	Morgan Stanley	Boost Target	Overweight	$70.00 ➝ $80.00	Medium
10/11/2018	Royal Bank of Canada	Boost Target	Outperform	$77.00	Low
10/8/2018	JPMorgan Chase & Co.	Boost Target	Overweight ➝ Overweight	$77.00 ➝ $81.00	Low
10/5/2018	Cowen	Boost Target	Outperform ➝ Average	$72.00 ➝ $86.00	Low
9/24/2018	Raymond James	Boost Target	Outperform ➝ Outperform	$72.00 ➝ $77.00	Medium
9/24/2018	Wells Fargo & Company	Boost Target	Outperform ➝ Outperform	$77.00 ➝ $80.00	Medium
7/19/2018	Royal Bank of Canada	Reiterated Rating	Buy	$70.00	Low
7/19/2018	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$71.00 ➝ $72.00	Medium
6/27/2018	Sanford C. Bernstein	Initiated Coverage	Outperform	$73.00	Medium
4/24/2018	Citigroup	Lower Target	Neutral ➝ Neutral	$66.00 ➝ $65.00	Low
4/22/2018	BTIG Research	Reiterated Rating	Hold		Low

(Data available from 2/7/2018 forward)

News Sentiment Rating

0.29 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

4 very positive mentions
24 positive mentions
5 negative mentions
9 very negative mentions

Mentions as of

7/12/2022

24 very positive mentions
64 positive mentions
8 negative mentions
7 very negative mentions

Mentions as of

8/11/2022

14 very positive mentions
31 positive mentions
17 negative mentions
7 very negative mentions

Mentions as of

9/10/2022

18 very positive mentions
25 positive mentions
7 negative mentions
4 very negative mentions

Mentions as of

10/10/2022

24 very positive mentions
59 positive mentions
8 negative mentions
5 very negative mentions

Mentions as of

11/9/2022

17 very positive mentions
13 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

12/9/2022

15 very positive mentions
20 positive mentions
2 negative mentions
2 very negative mentions

Mentions as of

1/8/2023

22 very positive mentions
50 positive mentions
3 negative mentions
11 very negative mentions

Mentions as of

2/7/2023

Current Sentiment

Recent Stories by Sentiment

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.

Today's Range

Now: $111.35

$109.97

$111.37

50 Day Range

MA: $109.86

$103.86

$114.01

52 Week Range

Now: $111.35

$93.25

$130.79

Volume

847,899 shs

Average Volume

4,843,972 shs

Market Capitalization

$194.15 billion

P/E Ratio

28.48

Dividend Yield

1.82%

Beta

0.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Abbott Laboratories?: The following sell-side analysts have issued reports on Abbott Laboratories in the last year: Bank of America Co., Barclays PLC, BTIG Research, Citigroup Inc., Cowen Inc, Cowen Inc., Erste Group Bank AG, Evercore ISI, Jefferies Financial Group Inc., Mizuho, Morgan Stanley, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for ABT.
What is the current price target for Abbott Laboratories?: 16 Wall Street analysts have set twelve-month price targets for Abbott Laboratories in the last year. Their average twelve-month price target is $125.63, suggesting a possible upside of 13.4%. Wells Fargo & Company has the highest price target set, predicting ABT will reach $140.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $110.00 for Abbott Laboratories in the next year.
View the latest price targets for ABT.
What is the current consensus analyst rating for Abbott Laboratories?: Abbott Laboratories currently has 1 sell rating, 3 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABT will outperform the market and that investors should add to their positions of Abbott Laboratories.
View the latest ratings for ABT.
What other companies compete with Abbott Laboratories?: Other companies that are similar to Abbott Laboratories include Novartis, AstraZeneca, Bristol-Myers Squibb, Pfizer and AbbVie. Learn More about companies similar to Abbott Laboratories.
How do I contact Abbott Laboratories' investor relations team?: Abbott Laboratories' physical mailing address is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. The healthcare product maker's listed phone number is (224) 667-6100. The official website for Abbott Laboratories is www.abbott.com. Learn More about contacing Abbott Laboratories investor relations.

Abbott Laboratories - ABT Stock Price Target and Predictions

Analyst Price Target for ABT

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.29 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Abbott Laboratories?

What is the current price target for Abbott Laboratories?

What is the current consensus analyst rating for Abbott Laboratories?

What other companies compete with Abbott Laboratories?

How do I contact Abbott Laboratories' investor relations team?